Tenet Healthcare Corporation

Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company that has operated since its incorporation in 1975, going public in 1980. Originally founded as a hospital operator, Tenet has transformed itself over the past decade into a healthcare enterprise focused on both acute care hospitals and ambulatory surgical centers. The company is headquartered in Dallas, Texas, and has undergone significant portfolio transformation in recent years, divesting hospitals while expanding its ambulatory care footprint through acquisitions and de novo development.

Over the past few years, Tenet Healthcare has undergone a significant strategic transformation focused on shifting from a traditional hospital operator to a diversified healthcare services company with emphasis on ambulatory care. The company has divested 14 hospitals, generating approximately $5 billion in gross proceeds, while simultaneously expanding its ambulatory surgery center portfolio by adding nearly 70 facilities through acquisitions and de novo development. The company has prioritized high-acuity service line expansion, particularly in orthopedics where total joint replacement procedures in ambulatory settings have grown 19% year-over-year. This shift capitalizes on the healthcare industry's movement toward lower-cost sites of care while maintaining or improving patient outcomes. Tenet has also invested heavily in robotic surgery capabilities and AI-enabled technologies to enhance operational efficiency and clinical outcomes. Capital deployment strategy has focused on investing approximately $250 million annually in ambulatory M&A opportunities while returning capital to shareholders through share repurchases. The company has retired approximately 14% of its outstanding shares and established new share repurchase programs totaling $1.5 billion. Operational improvements have included significant progress in labor management, reducing contract labor expenses and improving nurse retention through targeted recruitment and retention programs. The company has also enhanced its revenue cycle management capabilities and maintained strong patient experience scores, with USPI achieving a 96.6 patient experience rating. Looking forward, Tenet plans to continue its ambulatory expansion with 10-12 new de novo centers planned for 2025, while maintaining focus on operational discipline and preparing contingency plans for potential healthcare policy changes under new federal administration.